These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 23917321)

  • 21. Synergistic and antibiofilm activity of the antimicrobial peptide P5 against carbapenem-resistant Pseudomonas aeruginosa.
    Martinez M; Gonçalves S; Felício MR; Maturana P; Santos NC; Semorile L; Hollmann A; Maffía PC
    Biochim Biophys Acta Biomembr; 2019 Jul; 1861(7):1329-1337. PubMed ID: 31095945
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Potential novel therapeutic strategies in cystic fibrosis: antimicrobial and anti-biofilm activity of natural and designed α-helical peptides against Staphylococcus aureus, Pseudomonas aeruginosa, and Stenotrophomonas maltophilia.
    Pompilio A; Crocetta V; Scocchi M; Pomponio S; Di Vincenzo V; Mardirossian M; Gherardi G; Fiscarelli E; Dicuonzo G; Gennaro R; Di Bonaventura G
    BMC Microbiol; 2012 Jul; 12():145. PubMed ID: 22823964
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Critical Assessment of Methods to Quantify Biofilm Growth and Evaluate Antibiofilm Activity of Host Defence Peptides.
    Haney EF; Trimble MJ; Cheng JT; Vallé Q; Hancock REW
    Biomolecules; 2018 May; 8(2):. PubMed ID: 29883434
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mechanisms of biofilm inhibition and degradation by antimicrobial peptides.
    Segev-Zarko L; Saar-Dover R; Brumfeld V; Mangoni ML; Shai Y
    Biochem J; 2015 Jun; 468(2):259-70. PubMed ID: 25761937
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A novel hydroxyapatite-binding antimicrobial peptide against oral biofilms.
    Yang Y; Xia L; Haapasalo M; Wei W; Zhang D; Ma J; Shen Y
    Clin Oral Investig; 2019 Jun; 23(6):2705-2712. PubMed ID: 30353289
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy of the combination of tobramycin and a macrolide in an in vitro Pseudomonas aeruginosa mature biofilm model.
    Tré-Hardy M; Nagant C; El Manssouri N; Vanderbist F; Traore H; Vaneechoutte M; Dehaye JP
    Antimicrob Agents Chemother; 2010 Oct; 54(10):4409-15. PubMed ID: 20696878
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A short peptide with selective anti-biofilm activity against Pseudomonas aeruginosa and Klebsiella pneumoniae carbapenemase-producing bacteria.
    Cardoso MH; Santos VPM; Costa BO; Buccini DF; Rezende SB; Porto WF; Santos MJ; Silva ON; Ribeiro SM; Franco OL
    Microb Pathog; 2019 Oct; 135():103605. PubMed ID: 31228542
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of bacterial biofilm formation and swarming motility by a small synthetic cationic peptide.
    de la Fuente-Núñez C; Korolik V; Bains M; Nguyen U; Breidenstein EB; Horsman S; Lewenza S; Burrows L; Hancock RE
    Antimicrob Agents Chemother; 2012 May; 56(5):2696-704. PubMed ID: 22354291
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Peptide Mix from
    Gasu EN; Ahor HS; Borquaye LS
    Biomed Res Int; 2019; 2019():5313918. PubMed ID: 31662981
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antibacterial, anti-biofilm and in vivo activities of the antimicrobial peptides P5 and P6.2.
    Martínez M; Polizzotto A; Flores N; Semorile L; Maffía PC
    Microb Pathog; 2020 Feb; 139():103886. PubMed ID: 31778756
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition and Eradication of Pseudomonas aeruginosa Biofilms by Host Defence Peptides.
    Chen H; Wubbolts RW; Haagsman HP; Veldhuizen EJA
    Sci Rep; 2018 Jul; 8(1):10446. PubMed ID: 29993029
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Use of Calgary and Microfluidic BioFlux Systems To Test the Activity of Fosfomycin and Tobramycin Alone and in Combination against Cystic Fibrosis Pseudomonas aeruginosa Biofilms.
    Díez-Aguilar M; Morosini MI; Köksal E; Oliver A; Ekkelenkamp M; Cantón R
    Antimicrob Agents Chemother; 2018 Jan; 62(1):. PubMed ID: 29084746
    [No Abstract]   [Full Text] [Related]  

  • 33. Effect of Bacoside A on growth and biofilm formation by Staphylococcus aureus and Pseudomonas aeruginosa.
    Parai D; Islam E; Mitra J; Mukherjee SK
    Can J Microbiol; 2017 Feb; 63(2):169-178. PubMed ID: 28099040
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synthetic dendrimeric peptide active against biofilm and persister cells of Pseudomonas aeruginosa.
    Bahar AA; Liu Z; Totsingan F; Buitrago C; Kallenbach N; Ren D
    Appl Microbiol Biotechnol; 2015 Oct; 99(19):8125-35. PubMed ID: 26012420
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antibiofilm potential of flavonoids extracted from Moringa oleifera seed coat against Staphylococcus aureus, Pseudomonas aeruginosa and Candida albicans.
    Onsare JG; Arora DS
    J Appl Microbiol; 2015 Feb; 118(2):313-25. PubMed ID: 25410525
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Influence of roxithromycin combined with fleroxacin on bacterial biofilm induced by Pseudomonas aeruginosa].
    Chen Q; Wang R; Fang X
    Zhonghua Yi Xue Za Zhi; 1999 Oct; 79(10):757-60. PubMed ID: 11715522
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of natural curcuminoids-intercalated layered double hydroxide nanohybrid against Staphylococcus aureus, Pseudomonas aeruginosa, and Enterococcus faecalis: A bactericidal, antibiofilm, and mechanistic study.
    Gayani B; Dilhari A; Wijesinghe GK; Kumarage S; Abayaweera G; Samarakoon SR; Perera IC; Kottegoda N; Weerasekera MM
    Microbiologyopen; 2019 May; 8(5):e00723. PubMed ID: 30221843
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The antimicrobial agent, Next-Science, inhibits the development of Staphylococcus aureus and Pseudomonas aeruginosa biofilms on tympanostomy tubes.
    Banerjee D; Tran PL; Colmer-Hamood JA; Wang JC; Myntti M; Cordero J; Hamood AN
    Int J Pediatr Otorhinolaryngol; 2015 Nov; 79(11):1909-14. PubMed ID: 26388185
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A scorpion venom peptide derivative BmKn‒22 with potent antibiofilm activity against Pseudomonas aeruginosa.
    Teerapo K; Roytrakul S; Sistayanarain A; Kunthalert D
    PLoS One; 2019; 14(6):e0218479. PubMed ID: 31199859
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antibacterial activity of chensinin-1b, a peptide with a random coil conformation, against multiple-drug-resistant Pseudomonas aeruginosa.
    Shang D; Meng X; Zhang D; Kou Z
    Biochem Pharmacol; 2017 Nov; 143():65-78. PubMed ID: 28756209
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.